Epigenic Therapeutics
PrivateLast Round
Series B
Sep 7, 2025
Total Funding Raised
$112M
Momentum Score
75 /100
Company Overview
Epigenic is a biotechnology company specializing in gene-silencing technology aimed at treating a range of diseases through epigenome editing and gene editing therapies for conditions such as ophthalmology, neurodegeneration, metabolism, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epigenic Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Epigenic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 7, 2025 | ||||
| Series A | Aug 29, 2023 | ||||
| Seed | Aug 6, 2022 |
Key People
Founding team and executive leadership
Epigenic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FountainBridge Capital | Seed |
| Lapam Capital | Series B |
| Tigeryeah Capital | Seed |
| OrbiMed | Series B, Series A |
| Trinity Innovation Fund | Seed |
| Qiming Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2025
$60M round completed.
Epigenic Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Epigenic Therapeutics's valuation, stock price, and market status.
